Halaman 2 - Kondrosarkoma Dokter Terbaik - TOP-60 dokter

Direktur hematologi onkologi anak di Sourasky Medical Center – spesialis dalam pengobatan kanker tulang pada anak-anak.

• Ahli dalam pengobatan sarkoma pada anak-anak
• Menjalani pelatihan di Rizzoli Orthopaedic Institute – pusat terkemuka di dunia
• Mengoordinasikan pengobatan kanker tulang dengan tim onkologi-ortopedi
• Anggota ISPHO – Asosiasi hemato-onkologi anak Israel

Dr. Yildiz berspesialisasi dalam tumor neuroendokrin dan telah menulis lebih dari 17 artikel internasional yang ditinjau sejawat, termasuk mengenai kondisi terkait kondrosarkoma.

• Menerbitkan penelitian tentang kasus tumor langka seperti pemfigus paraneoplastik dan timoma
• Keahlian dalam mendiagnosis dan menangani kanker terkait endokrin yang kompleks
• Bekerja di Rumah Sakit Universitas Medipol Mega – pusat medis terkemuka di Turki

Memimpin departemen yang didedikasikan untuk lesi tulang metastatik di Ichilov Medical Center – salah satu rumah sakit terbesar di Israel.

• Berespesialisasi khusus dalam ortopedi onkologi, menangani kanker tulang.
• Menyelesaikan magang klinis tingkat lanjut di Israel dan Amerika Serikat.
• Memegang posisi akademik senior sebagai Profesor di Universitas Tel Aviv.
• Menempuh pendidikan di Universitas Ibrani Yerusalem yang bergengsi.

Prof. Köstler ahli dalam terapi kanker terarget, dengan pengalaman lebih dari dua dekade dalam perawatan kanker secara individual di Wiener Privatklinik.

• Pakar dalam kanker payudara dan keganasan ginekologi
• Associate Professor di Universitas Kedokteran Wina
• Fokus pada pengembangan biomarker dan biologi tumor
• Peserta aktif dalam jaringan onkologi Eropa

Dr. Amir adalah spesialis dalam bedah penyelamatan anggota tubuh untuk kanker tulang dan jaringan lunak di Sourasky Medical Center Israel (Ichilov).

• Menjalani pelatihan fellowship dalam onkologi ortopedi di National Cancer Institute AS dan University of Toronto
• Anggota aktif dari American Musculoskeletal Tumor Society (MSTS) dan International Society of Limb Salvage (ISOLS)
• Pemenang berbagai penghargaan, termasuk Tannenbaum Grant untuk keunggulan dalam onkologi bedah
• Berfokus pada sarkoma, dengan keahlian dalam kasus-kasus kompleks yang memerlukan teknik rekonstruksi

Profesor Keil memimpin Klinik Radiologi Diagnostik dan Intervensi di Rumah Sakit Akademik Solingen, dengan spesialisasi pencitraan tingkat lanjut untuk kasus-kasus kompleks.

• Lulus dengan pujian dari Julius-Maximilians-Universität Würzburg
• Ahli dalam MRI, CT, dan intervensi yang dipandu ultrasonografi
• Mantan dokter terkemuka di Rumah Sakit Universitas Aachen
• Spesialis dalam pencitraan cross-sectional untuk semua wilayah tubuh

Assoc. Prof. Nail Paksoy membawa keahlian khusus dalam sarkoma tulang dari Institut Onkologi Universitas Istanbul, kini memimpin perawatan kondrosarkoma di Rumah Sakit Medipol Bahçelievler.

• Mendapatkan sertifikasi dewan dalam onkologi medis oleh ESMO
• Menulis penelitian utama tentang kemoterapi dosis tinggi untuk sarkoma Ewing dan tumor tulang lainnya
• Berpartisipasi dalam uji klinis internasional untuk tumor padat fusi-NTRK
• Menjalani pelatihan fellowship di salah satu pusat onkologi terkemuka di Turki

Dr. Alemdar spesialis dalam kondrosarkoma di Medical Park Antalya, membawa keahlian onkologi terfokus pada kasus kanker tulang langka.

• Tersertifikasi dalam onkologi medis dengan pelatihan ekstensif
• Pengalaman di berbagai rumah sakit universitas terkemuka di Turki
• Spesialisasi dalam penyakit dalam sebelum spesialisasi onkologi

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Spesialisasi dalam viroterapi – salah satu bidang imunologi terbaru – Dr. Jaunalksne membawa 30+ tahun pengalaman dalam mengobati kondrosarkoma.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam
• Fokus pada pendekatan imunologis inovatif untuk pengobatan kanker

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Spesialisasi dalam onkologi radiasi di Universitas Marmara, dengan fokus pada pengobatan kondrosarkoma.

• Terlatih di Fakultas Kedokteran Universitas Marmara yang ternama
• Spesialisasi dalam onkologi radiasi dari 2012-2016
• Lulus dari program sarjana Fakultas Kedokteran Universitas Marmara (Bahasa Inggris)
• Menyediakan rencana terapi radiasi yang disesuaikan secara personal

Lebih dari 50.000 operasi kanker selama 19 tahun – Dr. Nagarkar spesialis dalam pengangkatan tumor kompleks dengan tetap menjaga kualitas hidup di HCG Manavata Cancer Centre.

• Menjalani pelatihan di Tata Memorial Hospital dan Royal College of Surgeons
• Melakukan 200+ uji klinis pada pengobatan kanker baru
• Profesor untuk DNB Superspecialty Surgical Oncology
• Fokus khusus pada onkologi payudara dan toraks